Core Viewpoint - Xylem Inc, a leading global water technology company, is facing challenges despite reporting strong quarterly earnings, with revised forecasts falling short of market expectations [2][3][4]. Financial Performance - Xylem reported fourth-quarter earnings per share of $1.42, slightly above the consensus estimate of $1.41 [2][6]. - Quarterly sales reached $2.397 billion, surpassing the expected $2.374 billion [3][6]. - The company's forecast for fiscal year 2026 adjusted earnings per share is between $5.35 and $5.56, below market estimates of $5.56 [3]. - Xylem anticipates sales between $9.1 billion and $9.2 billion, falling short of the expected $9.331 billion [3]. Market Reaction - Following the earnings report, Xylem's shares fell by 2.1% to $126.24 [4][6]. - Goldman Sachs set a revised price target of $158 for Xylem, down from a previous target of $175, indicating a potential increase of about 24.64% from the current stock price of $126.77 [2][6]. Stock Performance - Currently, Xylem is trading at $126.77, reflecting a decrease of 1.67% or $2.15 [5]. - The stock has fluctuated between $125.92 and $131.73 on the day, with a yearly high of $154.27 and a low of $100.47 [5]. - The company's market capitalization is approximately $30.86 billion, with a trading volume of 2,951,416 shares on the NYSE [5].